Article
The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosis.
Molecular therapy : the journal of the American Society of Gene Therapy - 1 Feb 2000
Meng R D, McDonald E R, Sheikh M S, Fornace A J, El-Deiry W S
Abstract excerpt
The cell surface decoy receptor proteins TRID (also known as DcR1 or TRAIL-R3) and TRUNDD (DcR2, TRAIL-R4) inhibit caspase-dependent cell death induced by the cytotoxic ligand TRAIL in part because of their absent or truncated cytoplasmic death domains, respectively. We previously identified the death domain containing proapoptotic TRAIL death receptor KILLER/DR5 (TRAIL-R2) as an upregulated transcript following...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.